117.06CHF+1.58%Mkt Cap: 227.54B CHFP/E: 20.79Last update: 2026-05-13
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…
Industry Peers
Pharmaceuticalsloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)20.79
P/E (Forward)—
PEG—
P/B6.24
P/S4.05
EV/EBITDA11.57
EV/Revenue4.69
EPS (TTM)5.63
EPS (Forward)—
Cash Flow & Leverage
FCF Yield5.28%
FCF Margin21.25%
Operating CF19.14B CHF
CapEx (TTM)3.90B CHF
Net Debt/EBITDA1.75
Net Debt40.11B CHF
Technical
SMA 50117.47 (-0.3%)
SMA 200117.47 (-0.3%)
Beta0.49
S&P 52W Chg24.23%
Avg Vol (30d)129.98K
Avg Vol (10d)130.00K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—
52W Range
108.8455% of range123.70
52W High123.70 CHF
52W Low108.84 CHF
Profitability
Gross Margin75.83%
EBITDA Margin40.51%
Profit Margin24.67%
Oper. Margin30.48%
ROE30.31%
ROA12.60%
Revenue Growth-0.70%
Earnings Growth-9.30%
Balance Sheet
Debt/Equity0.77
Current Ratio0.85
Quick Ratio0.53
Book Value/Sh18.88 CHF
Cash/Share3.612 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate4.666 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Ownership
Shares Out.0
Float1.82B
Insiders—
Institutions—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap227.54B CHF
Enterprise Value265.18B CHF
Revenue (TTM)56.58B CHF
Gross Profit42.98B CHF
Net Income (TTM)13.98B CHF
Revenue/Share29.40 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.3K
Last Price117.06 CHF
CountryCH
SectorHealth Care
IndustryPharmaceuticals
ISINCH0012005267